Clear effect in pre-clinical study
Press ReleasesSangair team can share some exciting news. Our ongoing pre-clinical study shows a clear effect. SangAspet™ lowers the number of…
Read ArticlePress Releases
Media
Sangair patent is approved in Canada
Press ReleasesThe intellectual property family has expanded with an approved patent application in Canada, pertaining to ozonation of blood, and more…
Read ArticleSangair strengthens the board of Directors
Press ReleasesAt the annual bord meeting on the 16th of June the shareholders added two new board members, Susanne Olausson and…
Read ArticleImportant patent granted in Japan
Press ReleasesDuring the last year, marked by a pandemic, Sangair has worked hard to create a proof of concept for its…
Read Article